PGRMC1 originally was identified by expression induction during carcinogenesis in liver cancer (Nie et al., 2006), and recently was observed its elevation with tumor stage in ovarian cancer and estrogen receptor-negative breast cancer (Neubauer et al., 2008). The gene discussed is ESR1; the disease is ovarian carcinoma.